Health News-RSS Feeds

ECB sounds out lenders on exposure to Spanish drugmaker Grifols 

January 17, 2024 - 11:29pm

Reuters exclusively reported that the European Central Bank was asking banks to detail their exposure to Spanish drugmaker Grifols and a network of companies linked to the founding family, days after the Barcelona-based business was accused of manipulating its financial accounts by a short-seller. The story also revealed how supervisors were concerned that the huge drop in Grifols’ share price could require family-connected companies which have borrowed using Grifols stock as collateral to post more margin. Grifols denies all the allegations made by Gotham City Research, the short-seller. The story was picked up by Bloomberg, Spain’s state-owned news agency, EFE, and made it into several newspapers including Expansion, El Mundo and the front page of business daily Cinco Dias. 

The post ECB sounds out lenders on exposure to Spanish drugmaker Grifols  appeared first on Reuters News Agency.

US FDA finds control lapses at Moderna manufacturing plant 

December 15, 2023 - 3:12pm

Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine. 

The post US FDA finds control lapses at Moderna manufacturing plant  appeared first on Reuters News Agency.

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

November 17, 2023 - 5:01pm

Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies. 

The post Lilly to build $2.5 billion Germany plant as obesity drug demand soars appeared first on Reuters News Agency.